Who is Protalix Biotherapeutics Inc
Protalix Biotherapeutics Inc operates in the healthcare sector, with around 226 employees worldwide. The stock has a market capitalisation of $0.2 billion, trading at a price-to-earnings (P/E) ratio of 11.5.
Frequently asked questions
What dividend does this stock pay?
The dividend yield isn't available in our data sheet at the moment; check the official figures on the company's investor relations website.
Which ETFs include this stock?
Presence in specific ETFs isn't available in our data sheet at the moment.
How are dividends from foreign shares taxed in the UK?
Outside an ISA, UK dividend tax applies to worldwide dividend income above the dividend allowance, with relief available under the UK-Italy double taxation treaty for any Italian withholding tax — see our UK dividend tax guide.
